Consultant, Surgical Oncology, Artemis Hospitals, Gurugram
Part 2 of 10 in Diagnosis and Management of Esophageal Cancer
Early Warning Signs and Symptoms of Esophageal Cancer
September 6, 2026
Esophageal cancer's biggest clinical challenge isn't treating it, it's catching it before it has already become locally advanced. Most patients present late because the earliest symptoms are easy to write off as something else entirely.
The Subtle Early Picture
In a genuinely early-stage malignancy, most patients have no symptoms at all, or at most slight discomfort while swallowing. When difficulty does appear, it follows a distinctive pattern: it is progressive, it affects solid food well before it ever affects liquids, and it is easy to dismiss as a minor, temporary problem. Because of this, the real early-stage cases that do get diagnosed are almost always picked up through screening endoscopy in settings with a stringent screening protocol, catching dysplastic changes and early malignancy before symptoms would ever have forced the issue.
How Advanced Disease Presents
By the time the disease has become more advanced, the symptoms turn far more classical. Dysphagia becomes more pronounced and is often not associated with pain. Weight loss becomes unintentional and progressive, and is considered clinically significant once a patient has lost around 10 percent of body weight in under three months. Some patients develop heartburn-like symptoms, regurgitation, or a sensation of food getting stuck in the throat. More aggressive or obstructive tumours can cause vomiting, sometimes with blood. Once the tumour advances far enough to invade nearby structures, it can also produce coughing and hoarseness of voice.
What This Means for Referral
Any patient with progressive difficulty swallowing, regardless of how mild, warrants an endoscopic evaluation rather than a wait-and-watch approach. Waiting for the classical advanced symptoms, weight loss, blood-streaked vomiting, hoarseness, to appear before referring for endoscopy means waiting until the disease is already locally advanced, which is precisely the pattern responsible for the disease's poor outcomes across the region.
This article is based on a Jivo Masterclass session conducted by Dr. Preeti Vijayakumaran, Consultant, Surgical Oncology, Artemis Hospital, Gurugram. The article has been summarised with the assistance of an AI tool from the original masterclass recording. Watch the full Masterclass recording
This guide is based on a live Jivo Masterclass: Dr. Preeti Vijayakumaran taught doctors across Africa on March 16, 2025.
FROM THE LIVE Q&A
Dr. Mukia
What is the role of immunotherapy in esophageal cancer?
Dr. Preeti Vijayakumaran
Immunotherapy's role is currently established in the adjuvant setting, more so for esophageal squamous cell carcinoma. A patient who completes neoadjuvant therapy, undergoes surgery, and is found to have residual disease is followed with adjuvant nivolumab. If there is no residual disease, adjuvant nivolumab is not advocated. In the neoadjuvant setting, the role of immunotherapy is still experimental and yet to be answered.
Book a Consultation with Dr. Preeti Vijayakumaran
Book on WhatsAppOr message us on WhatsApp: +91 98182 98669
Frequently Asked Questions
Cryotherapy is one of the treatment options for the cancer. Would you repeat the disadvantages of applying cryotherapy for esophageal cancer?▼
Cryotherapy, along with other ablative therapies, is applicable only in very early and especially screen-detected cases of esophageal malignancy. Staging accuracy is critical here: if endoscopy and endoscopic ultrasound confirm a flat, high-grade dysplastic lesion or an early intramucosal carcinoma, ablation can be applied, though it does leave structural changes at the site that make future surveillance harder. If there is any suspicion of nodular disease, or of invasion into the submucosa or muscularis propria, endoscopic resection is recommended over an ablative procedure like cryotherapy alone.
Given that the prevalence is much higher in men than in women, is there a predisposing genetic factor?▼
This is a question on my mind as well. There is no established genetic risk factor explaining why esophageal cancer is more common in men than women. A lot of it is attributed to other risk factors instead, like smoking habits and diet habits, but on the genetic side there really isn't an answer yet.
In cases of widespread metastasis, can chemotherapy improve the prognosis?▼
Yes. In widespread metastasis there is a possible benefit from chemotherapy combined with immunotherapy or targeted therapy. How much survival advantage this brings is, statistically, maybe a couple of months, but it will definitely improve the patient's quality of life during that period.
What is the role of imaging in the workup of esophageal cancer?▼
Essentially, whole-body axial imaging: a PET-CT if it is available, and if not, a contrast-enhanced scan covering the neck, thorax, abdomen and pelvis for staging. In addition, endoscopic ultrasound is used in early-stage disease for more accurate T and N staging, and bronchoscopy and laparoscopy may be used in locally advanced disease, laparoscopy specifically to rule out peritoneal metastasis in cases of adenocarcinoma.
What are the methods of preventing esophageal cancer?▼
Prevention starts with understanding the risk factors, which depend on the histological subtype. For adenocarcinoma, the drivers can be obesity, reflux disease, and smoking and alcohol, so limiting smoking and alcohol matters, and an existing reflux disease needs to be managed medically. Patients with an already existing condition should also be started early on more stringent endoscopic surveillance. For squamous cell carcinoma, the pathology is more related to smoking and diet habits, and regulating those can make a difference.
What is the earliest symptom of esophageal cancer?▼
Slight discomfort or mild, progressive difficulty swallowing that affects solid food before it affects liquids; many early-stage patients have no symptoms at all.
How is significant weight loss defined in esophageal cancer?▼
Losing around 10 percent of body weight in under three months is considered clinically significant and warrants investigation.
Why does esophageal cancer often present late?▼
Its early symptoms are subtle and easy to dismiss, so most genuine early-stage cases are only caught through screening endoscopy rather than symptom-driven presentation.
In This Series: Diagnosis and Management of Esophageal Cancer
- 1.Diagnosis and Management of Esophageal Cancer
- 2.Early Warning Signs and Symptoms of Esophageal Cancer
- 3.How Esophageal Cancer Is Diagnosed and Staged
- 4.Telling Gastroesophageal Junction Cancer Apart From Lower Esophageal Cancer
- 5.Treating Early-Stage Esophageal Cancer: When Endoscopy Can Replace Surgery
- 6.Managing Locally Advanced Esophageal Cancer: What the Major Trials Show
- 7.Esophagectomy: How the Surgery Is Performed, and the Shift Toward Robotic Techniques
- 8.Immunotherapy in Esophageal Cancer: Where the Evidence Stands Today
- 9.Screening, Prevention and Risk Factors for Esophageal Cancer
- 10.Life After Treatment: Surveillance for Esophageal Cancer and Managing Recurrence